Beryl Drugs Submits Regulatory Filings for Quarter Ended Sep'26
Beryl Drugs Ltd 路 Others (Uncategorized) 路 08 Oct 2026, 12:14 am
Beryl Drugs Submits Regulatory Filings for Quarter Ended Sep'26 Beryl Drugs Limited has submitted quarterly compliance filings to BSE for the period ended 30th Sep'26. The company enclosed the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, alongside a non-applicability certificate under Regulation 57(5) of SEBI LODR Regulations. Beryl Drugs confirmed that Regulation 57(5) is not applicable as it has no non-convertible securities with interest, dividend, or principal obligations payable during the quarter ended 30th Sep'26.
Original exchange filing (PDF)
More announcements from Beryl Drugs Ltd
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.09.2026 路 14 Nov 2026
- OUTCOME OF BOARD MEETING 路 14 Nov 2026
- Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve to consider and approve unaudited .... 路 14 Nov 2026
- VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026 路 01 Oct 2026
- PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD. 路 29 Sept 2026
- OUTCOME OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- ANNUAL REPORT 2025-2026 路 04 Sept 2026
